A consensus prognostic gene expression classifier for ER positive breast cancer

A consensus prognostic gene expression classifier for ER positive breast cancer

A consensus prognostic classifier for estrogen receptor positive breast tumors has been developed and shown to be valid in nearly 900 samples across different microarray platforms.

Bibliographic Details
Main Authors:	Teschendorff, Andrew E, Naderi, Ali, Barbosa-Morais, Nuno L, Pinder, Sarah E, Ellis, Ian O, Aparicio, Sam, Brenton, James D, Caldas, Carlos
Format:	Online
Language:	English
Published:	BioMed Central 2006
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794561/

Similar Items

Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling
by: Naderi, Ali, et al.
Published: (2004)

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
by: Chin, Suet F, et al.
Published: (2007)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
by: Ali, H R, et al.
Published: (2012)

The prognostic effects of somatic mutations in ER-positive breast cancer
by: Obi L. Griffith, et al.
Published: (2018-09-01)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
by: Gao, Yang, et al.
Published: (2016)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
by: Gao, Yang, et al.
Published: (2015)

Molecular profiling of breast cancer: portraits but not physiognomy
by: Brenton, James D, et al.
Published: (2001)

A simple and reproducible prognostic index in luminal ER-positive breast cancers
by: Castellano, I., et al.
Published: (2013)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
by: Kim, Tae-Jung, et al.
Published: (2012)

PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations
by: Bendl, Jaroslav, et al.
Published: (2014)

The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
by: Pinder, Sarah E, et al.
Published: (2003)

Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer
by: Banerji, Christopher R. S., et al.
Published: (2015)

Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer
by: Teschendorff, Andrew E, et al.
Published: (2015)

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
by: Blenkiron, Cherie, et al.
Published: (2007)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
by: Sasagu Kurozumi, et al.
Published: (2017-05-01)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
by: Jordan, VC
Published: (2005)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
by: Deng, Hao, et al.
Published: (2014)

A "non-parametric" version of the naive Bayes classifier
by: Soria, Daniele, et al.
Published: (2011)

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer
by: Jia, Xiao-qing, et al.
Published: (2015)

Breast cancer prognostic classifiers: combining clinical with molecular profiles
by: Muftah, Abir A. Abdelhadi
Published: (2017)

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy
by: Froehner, Michael, et al.
Published: (2014)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
by: Parmar, Chintan, et al.
Published: (2015)

Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes
by: Ashkani, Jahanshah, et al.
Published: (2016)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
by: Reese, Jordan M, et al.
Published: (2014)

Coeliac disease: to classify or not to classify – that is the question!
by: Ensari, Arzu
Published: (2016)

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations
by: Grivas, Petros D., et al.
Published: (2009)

Assessing excellence in translational cancer research: a consensus based framework
by: Rajan, Abinaya, et al.
Published: (2013)

An association-adjusted consensus deleterious scheme to classify homozygous Mis-sense mutations for personal genome interpretation
by: Preeprem, Thanawadee, et al.
Published: (2013)

Uniform Standards and Case Definitions for Classifying Opioid-Related Deaths: Recommendations by a Samhsa Consensus Panel
by: Goldberger, Bruce A., et al.
Published: (2013)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
by: Wrzesiński, Tomasz, et al.
Published: (2015)

Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
by: Danza, Katia, et al.
Published: (2014)

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?
by: Child, J. A.
Published: (1991)

Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?
by: Aparicio, Samuel AJR, et al.
Published: (2000)

SEARCHING CLASSIFIED PATENT SPECIFICATIONS
by: E.M., BENNETT
Published: (1952)

CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance
by: Gao, Tian, et al.
Published: (2014)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
by: Gökmen-Polar, Yesim, et al.
Published: (2015)

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
by: Dubsky, P., et al.
Published: (2013)

FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017)

Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.
by: Benson, J. R., et al.
Published: (1996)

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
by: Shen, Kui, et al.
Published: (2012)